AAVantgarde Bio

About:

AAVantgarde Bio is a biotechnology company that develops gene therapies for inherited retinal disorders.

Website: https://www.aavantgarde.com/

Top Investors: Atlas Venture, Longwood Fund, Sofinnova Partners, Forbion Capital Partners, Fondazione Telethon

Description:

AAVantgarde Bio is developing gene therapies for inherited retinal disorders.

Total Funding Amount:

61M EUR

Headquarters Location:

Milano, Lombardia, Italy

Founded Date:

2021-01-01

Contact Email:

info(AT)aavantgardebio.com

Founders:

Alberto Auricchio

Number of Employees:

11-50

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries: